In children ages 1 to 3 years assigned to the patch during the randomized portion of the trial, the percentage whose bodies achieved an eliciting dose (ED) of at least 1,000 mg without a reaction -- equivalent to about three or four peanuts -- grew from 74.7% at the initial 12-month analysis to 81.3% at 24 months, reported Matthew Greenhawt, of Children’s Hospital Colorado [and CU School of Medicine] in Aurora.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045